MetLife Investment Management’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $134K | Buy |
24,953
+1,604
| +7% | +$8.6K | ﹤0.01% | 2393 |
|
|
2025
Q1 | $125K | Sell |
23,349
-3,656
| -14% | -$19.5K | ﹤0.01% | 2419 |
|
|
2024
Q4 | $241K | Hold |
27,005
| – | – | ﹤0.01% | 2205 |
|
|
2024
Q3 | $297K | Hold |
27,005
| – | – | ﹤0.01% | 2068 |
|
|
2024
Q2 | $246K | Buy |
27,005
+1,342
| +5% | +$12.2K | ﹤0.01% | 2121 |
|
|
2024
Q1 | $361K | Buy |
25,663
+12,090
| +89% | +$170K | ﹤0.01% | 1854 |
|
|
2023
Q4 | $104K | Hold |
13,573
| – | – | ﹤0.01% | 2593 |
|
|
2023
Q3 | $101K | Hold |
13,573
| – | – | ﹤0.01% | 2569 |
|
|
2023
Q2 | $113K | Buy |
+13,573
| New | +$113K | ﹤0.01% | 2603 |
|